Abstract
Obesity develops in an individual when energy intake exceeds energy expenditure over a prolonged period and the excess is stored as triglyceride, predominantly in adipose tissue. The rising prevalence of obesity worldwide is a major contributor to poor health, including diabetes, heart disease, and cancer. To understand the pathogenesis of obesity, it is important to understand the regulation of energy balance, which, although very tightly regulated, is subject to biological variation and easily overwhelmed by societal pressures and marketing influences. Control pathways for food intake and energy expenditure during as well as between meals include short-term mechanisms that operate from gastrointestinal tract to the central nervous system, as well as long-term signals that regulate the “set point” for body weight, which are dominated by leptin, an adipocyte-derived hormone. These pathways converge in the central nervous system, notably the hypothalamus, which plays a vital role in controlling food intake, energy expenditure, and other aspects of metabolism. Various genetic and environmental factors can influence these energy homeostasis mechanisms. Foods that are high in sugars and fat are potent rewards that promote eating even in the absence of absolute energy requirement, particularly in modern societies where food is available in abundance, and contribute to the obesity epidemic. Single gene disorders that result in obesity such as leptin deficiency and mutations in the pro-opiomelanocortin gene are rare but demonstrate the biological importance of these systems. Other etiological factors in some people may include drugs that increase appetite through central or peripheral mechanisms and structural damage to the hypothalamic areas involved in control of appetite. However, the recent increase in the prevalence of obesity is predominantly due to adverse environmental factors that are able to override these regulatory systems. These include widespread availability of high-energy foods, coupled with an unprecedented decline in levels of physical activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–60.
Weltens N, Iven J, Van Oudenhove L, Kano M. The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation. Ann N Y Acad Sci. 2018;1428(1):129–50.
Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homolog. Nature. 1994;372:425–32.
Tartaglia LA, Dembski M, Weng X, Deng NH, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, Ob-r. Cell. 1995;83:1263–71.
Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Investig. 1996;98:1101–6.
Farooqi IS, Bullmore E, Keogh J, Gillard J, O'Rahilly S, Fletcher PC. Leptin regulates striatal regions and human eating behavior. Science. 2007;317(5843):1355.
Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev. 1992;13:387–413.
Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CMB, Meeran K, et al. A role for glucagon-like peptide-1 in the central control of feeding. Nature. 1996;379:69–72.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.
Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349(10):941–8.
Rodgers RJ, Tschop MH, Wilding JPH. Anti-obesity drugs: past, present and future. Dis Model Mech. 2012;5(5):621–6.
Hall KD, Obesity Energetics GJ. Body weight regulation and the effects of diet composition. Gastroenterology. 2017;152(7):1718-27.e3.
Dulloo AG. Translational issues in targeting brown adipose tissue thermogenesis for human obesity management. Ann N Y Acad Sci. 2013;1302(1):1–10.
von Loeffelholz C BA. The role of non-exercise activity thermogenesis in human Obesity: Endotext (internet); 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279077/?report=reader#_NBK279077_pubdet_
Melanson EL, Keadle SK, Donnelly JE, Braun B, King NA. Resistance to exercise-induced weight loss: compensatory behavioral adaptations. Med Sci Sports Exerc. 2013;45(8):1600–9.
Bray GA, Kim KK, Wilding JPH, World Obesity F. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity federation. Obes Rev. 2017;18(7):715–23.
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206.
Farooqi SI. Genetic, molecular and physiological mechanisms involved in human obesity: Society for Endocrinology medal lecture 2012. Clin Endocrinol. 2015;82(1):23–8.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889–94.
Khera AV, Chaffin M, Wade KH, Zahid S, Brancale J, Xia R, et al. Polygenic prediction of weight and Obesity trajectories from birth to adulthood. Cell. 2019;177(3):587-96.e9.
Clément K, Mosbah H, Poitou C. Rare genetic forms of obesity: from gene to therapy. Physiol Behav. 2020;227:113134.
Celis-Morales CA, Lyall DM, Gray SR, Steell L, Anderson J, Iliodromiti S, et al. Dietary fat and total energy intake modifies the association of genetic profile risk score on obesity: evidence from 48 170 UK biobank participants. Int J Obes. 2017;41(12):1761–8.
Hu FB. Television watching and other sedentary behaviors in relation to risk of Obesity and type 2 diabetes mellitus in women. JAMA. 2003;289(14):1785.
Ogilvie RP, Patel SR. The epidemiology of sleep and obesity. Sleep Health. 2017;3(5):383–8.
Wen CP, David Cheng TY, Tsai SP, Chan HT, Hsu HL, Hsu CC, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009;12(4):497–506.
Ralston J, Brinsden H, Buse K, Candeias V, Caterson I, Hassell T, et al. Time for a new obesity narrative. Lancet. 2018;392(10156):1384–6.
Seetho IW, Wilding JPH. How to approach endocrine assessment in severe obesity? Clin Endocrinol. 2013;79(2):163–7.
Wells JCK, Marphatia AA, Cole TJ, McCoy D. Associations of economic and gender inequality with global obesity prevalence: understanding the female excess. Soc Sci Med. 2012;75(3):482–90.
Zellner DA, Loaiza S, Gonzalez Z, Pita J, Morales J, Pecora D, et al. Food selection changes under stress. Physiol Behav. 2006;87(4):789–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Rajeev, S.P., Wilding, J.P.H. (2023). Etiopathogenesis of Obesity. In: Agrawal, S. (eds) Obesity, Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-60596-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-60596-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-60595-7
Online ISBN: 978-3-030-60596-4
eBook Packages: MedicineReference Module Medicine